NCT06296420

Brief Summary

The goal of this observational study is to develop a questionnaire for measuring swallowing and throat discomfort symptoms in patients with goiter or thyroidectomy, which complies with the model of Rasch and which satisfies the fundamental measurement axioms (e.g., unidimensionality, linearity, generalizability). Developing a scale with such characteristics would provide clinicians and researchers with a reliable tool for assessing the impact of goiter and for measuring the outcomes after surgery. Also, the study will assess the psychological impact of goiter and thyroidectomy, as well as the characteristics of the surgical scar after thyroidectomy. The questionnaire will be developed in the first phase of the study. Items and response categories will be identified through interviews performed with patients affected by goiter or after thyroidectomy. In the following phases of the study, the questionnaire will be administered to patients before and after thyroidectomy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
420

participants targeted

Target at P75+ for all trials

Timeline
6mo left

Started Jan 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Jan 2024Nov 2026

Study Start

First participant enrolled

January 31, 2024

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

February 29, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 6, 2024

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

2.8 years

First QC Date

February 29, 2024

Last Update Submit

December 17, 2025

Conditions

Keywords

Nodular goiterThyroidectomyDysphagiaPsychometricsRasch analysis

Outcome Measures

Primary Outcomes (1)

  • The primary outcome measure will be the questionnaire which will be developed in the first phase of the study itself.

    The questionnaire will be administered to the recruited patients three times: in the week before surgery, three months after surgery, and six months after surgery.

    In the week before surgery, three months after surgery, and six months after surgery.

Secondary Outcomes (2)

  • Patient and Observer Scar Assessment Scale (POSAS) 2.0.

    The POSAS 2.0 will be administered 10 days after surgery and 2 months after surgery.

  • Depression Anxiety Stress Scales-21 (DASS-21).

    The DASS-21 will be administered 10 days before surgery and 2 months after surgery.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In the first phase, the study will recruit patients with diagnosis of goiter who are candidates to thyroidectomy and patients who have undergone thyroidectomy. Patients will be interviewed by the researchers. The interviews will face the symptoms of goiter or thyroidectomy, dealing (not exclusively) with throat and swallowing symptoms. The interviews will be recorded and analysed. The content of the interviews will be used to develop the items and the response categories of the questionnaire. In the second phase, the study will recruit patients who are candidates for thyroidectomy. The questionnaire (and the other outcome measures of the study) will be administered to the patients before and after surgery. All patients who are candidates for thyroidectomy at the Istituto Auxologico Italiano in Milan, Italy, will be recruited (if they comply with inclusion and exclusion criteria and if they provide consent). General, clinical and surgical data will be collected.

You may qualify if:

  • Diagnosis of goiter or thyroidectomy.

You may not qualify if:

  • Diagnosis of other neurological disorders or disorders involving the aerodigestive tract that could cause swallowing disorders.
  • Previous surgery of the neck or involving the aerodigestive tract.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Istituto Auxologico Italiano

Milan, MI, 20122, Italy

RECRUITING

MeSH Terms

Conditions

GoiterThyroid DiseasesGoiter, NodularDeglutition Disorders

Condition Hierarchy (Ancestors)

Endocrine System DiseasesEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Stefano Scarano, MD

    University of Milan, IRCCS Istituto Auxologico Italiano

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Stefano Scarano, MD

CONTACT

Gianlorenzo Dionigi, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 29, 2024

First Posted

March 6, 2024

Study Start

January 31, 2024

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

December 18, 2025

Record last verified: 2025-12

Locations